Treatment with pamidronate for osteoporosis complicating long-term intestinal failure

Journal of Pediatric Gastroenterology and Nutrition

Volumn 55, Issue 5, 2012, Pages 615-618

  Pastore, S ^a   Londero, M ^a   Barbieri, F ^a   Di Leo, G ^b   Paparazzo, R ^b   Ventura, A ^a  

^a UNIVERSITY OF TRIESTE   (Italy)

^b INSTITUTE FOR MATERNAL AND CHILD HEALTH IRCCS BURLO GAROFOLO   (Italy)

Author keywords

Bone disease; Pamidronate; Parenteral nutrition

Indexed keywords

CALCIUM; PAMIDRONIC ACID; PHOSPHORUS; VITAMIN D;

ARTICLE; BODY HEIGHT; BODY MASS; BODY WEIGHT; BONE DENSITY; CHILD; CLINICAL ARTICLE; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; FOLLOW UP; HOME CARE; HUMAN; HYPOCALCEMIA; INTESTINAL FAILURE; MALE; OSTEOPOROSIS; PARENTERAL NUTRITION; PRIORITY JOURNAL;

ABSORPTIOMETRY, PHOTON; ADOLESCENT; BONE DENSITY; BONE DENSITY CONSERVATION AGENTS; CHILD; CHILD, PRESCHOOL; DIPHOSPHONATES; FEMALE; HUMANS; INTESTINAL DISEASES; MALE; OSTEOPOROSIS; PARENTERAL NUTRITION, HOME;

EID: 84869085147     PISSN: 02772116     EISSN: 15364801     Source Type: Journal    
DOI: 10.1097/MPG.0b013e31825f1c7d     Document Type: Article

References (17)

1. Kroger H, Kotaniemi A, Vainio P, et al. Bone densitometry of the spine and femur in children by dual energy x ray absorptiometry. Bone Miner 1992;17:75-85.
2. Nishikawa RA, Siepler SE, Siepler JK, et al. Intravenous pamidronate improves bone mineral density in home parenteral nutrition patients. Clin Nutr 2003;22:S88.
3. Haderslev KV, Tjellesen L, Sorensen HA, et al. Effect of cyclical intravenous clodronate therapy on bone mineral density and markers of bone turnover in patients receiving home parenteral nutrition. Am J Clin Nutr 2002;76:482-8.
4. Raman M, Aghdassi E, Baun M, et al. Metabolic bone disease in patients receiving home parenteral nutrition: A Canadian study and review. J Parenter Enteral Nutr 2006;30:492-6.
5. Peters C, Fischer JE. Studies on calorie to nitrogen ratio for total parenteral nutrition. Surg Gynecol Obstet 1980;151:1-8.
6. Wesley JR, Coran AG. Intravenous nutrition for the pediatric patient. Semin Pediatr Surg 1992;1:212-30.
7. Pironi L, Labate AM, Pertkiewicz M, et al. Prevalence of bone disease in patients on home parenteral nutrition. Clin Nutr 2002;21:289-96.
8. Shike M, Harrison JE, Sturtridge WC, et al. Metabolic bone disease in patients receiving long term total parenteral nutrition. Ann Intern Med 1980;92:343-50.
9. Harrison JE, Jeejeebhoy KN, Track NS. The effect of total parenteral nutrition (TPN) on bone mass. In: Coburn JW, Klein GL, eds. Metabolic Bone Disease in Bone Parenteral Nutrition. Baltimore, MD: Urban and Schwarzenberg; 1985:53.
10. Breaux CW Jr, Dukie D, Georgeson KE, et al. Calcium phosphate crystal occlusion of central venous catheters used for total parenteral nutrition in infants and children: Prevention and treatment. J Pediatr Surg 1987;22:829-32.
11. Buchman AL, Mourkarzel A. Metabolic bone disease associated with total parenteral nutrition. Clin Nutr 2000;19:217-31.
12. Koo WW, Tsang RC, Succop P, et al. Minimal vitamin D and high calcium and phosphorus needs of preterm infants receiving parenteral nutrition. J Pediatr Gastroenterol Nutr 1989;8:225-33.
13. Knapen MHJ, Hamulyak K, Vermeer C. The effect of vitamin K supplementation on circulating osteocalcin (bone Gla protein) and urinary calcium excretion. Ann Intern Med 1989;111:1001-5.
14. Diamanti A, Claudia Bizzarri C, Basso MS, et al. How does long-Term parenteral nutrition impact the bone mineral status of children with intestinal failure? J Bone Miner Metab 2010;28:351-8.
15. Falk MJ, Heeger S, Lynch KA, et al. Intravenous bisphosphonate therapy in children with osteogenesis imperfecta. Pediatrics 2003; 111:573-8.
16. Srivastava T, Alon US. The role of bisphosphonates in diseases of childhood. Eur J Pediatr 2003;162:735-51.
17. Steelman J, Zeitler P. Treatment of symptomatic pediatric osteoporosis with cyclic single-day intravenous pamidronate infusions. J Pediatr 2003;142:417-23.